Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Iovance Biotherapeutics Inc (IOVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,483,542
  • Shares Outstanding, K 89,640
  • Annual Sales, $ 0 K
  • Annual Income, $ -92,060 K
  • 36-Month Beta 5.94
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.07

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.90 +14.75%
on 05/01/18
17.20 -7.27%
on 05/21/18
+1.10 (+7.41%)
since 04/25/18
3-Month
13.60 +17.28%
on 04/06/18
19.90 -19.85%
on 03/13/18
-3.05 (-16.05%)
since 02/23/18
52-Week
4.45 +258.43%
on 08/16/17
19.90 -19.85%
on 03/13/18
+9.80 (+159.35%)
since 05/25/17

Most Recent Stories

More News
Iovance Biotherapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update

- Company to Host Conference Call at 4:30pm ET Today -

IOVA : 15.95 (-3.63%)
Iovance Biotherapeutics to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 10, 2018

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it will report...

IOVA : 15.95 (-3.63%)
Iovance Biotherapeutics to Present at Two Upcoming Investor Conferences in May

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that company management...

IOVA : 15.95 (-3.63%)
DB : 12.05 (-1.63%)
Technical Perspectives on Biotech Stocks -- Intrexon, Iovance Biotherapeutics, Jaguar Health, and Jazz Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on XON, IOVA, JAGX, and JAZZ which can be accessed for free by signing up to www.wallstequities.com/registration....

IOVA : 15.95 (-3.63%)
JAZZ : 165.02 (+0.88%)
XON : 15.66 (+1.03%)
JAGX : 0.14 (unch)
Report: Developing Opportunities within Enanta Pharmaceuticals, ServisFirst Bancshares, Lion Biotechnologies, Peapack-Gladstone Financial, Analogic, and Akcea Therapeutics -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Enanta Pharmaceuticals, Inc....

SFBS : 42.71 (-1.11%)
IOVA : 15.95 (-3.63%)
ENTA : 96.46 (-1.25%)
AKCA : 23.29 (-1.31%)
PGC : 35.24 (+2.23%)
ALOG : 83.60 (-0.06%)
LBIO : 6.95 (-2.80%)
Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today reported its fourth quarter and...

IOVA : 15.95 (-3.63%)
Iovance Biotherapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2017 Financial Results and Provide a Corporate Update on Monday, March 12, 2018

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it will report...

IOVA : 15.95 (-3.63%)
Iovance Biotherapeutics to Present at Two Upcoming Investor Conferences in March

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that company management...

IOVA : 15.95 (-3.63%)
Johnson Fistel, LLP Announces Investigations of RH, WageWorks, Inc., BRF S.A., and Iovance Biotherapeutics, Inc.; Investors Encouraged to Contact Firm

Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against RH, WageWorks, Inc., BRF S.A., and Iovance Biotherapeutics, Inc., as detailed below:

WAGE : 45.10 (+1.92%)
BRFS : 6.10 (-2.87%)
IOVA : 15.95 (-3.63%)
RH : 104.29 (+1.91%)
Is a Surprise Coming for Lion Biotechnologies (IOVA) This Earnings Season?

Lion Biotechnologies (IOVA) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.

IOVA : 15.95 (-3.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade IOVA with:

Business Summary

Iovance Biotherapeutics, Inc. is a biopharmaceutical company. It focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. Iovance Biotherapeutics Inc., formerly known as Lion Biotechnologies...

See More

Key Turning Points

2nd Resistance Point 16.95
1st Resistance Point 16.45
Last Price 15.95
1st Support Level 15.60
2nd Support Level 15.25

See More

52-Week High 19.90
Last Price 15.95
Fibonacci 61.8% 14.00
Fibonacci 50% 12.17
Fibonacci 38.2% 10.35
52-Week Low 4.45

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar